AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Tradjenta -- A prescription medicine that is used to treat type 2 diabetes. Otezla – A prescription pill that treats plaque ...

As the doctors told Annette Stalley she might need to be put on a ventilator, she realised it was a situation of her own ...

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...

Emphysema is a chronic lung condition that affects millions of people worldwide and can make everyday activities such as ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.

Increasing Prevalence of Asthma and COPD: The rising incidence of asthma and chronic obstructive pulmonary disease (COPD) ...

The announcement that inhaled insulin will soon be available in India has understandably generated a lot of excitement and ...

Scientists at Rutgers Health have discovered that a simple blood test could diagnose asthma and determine its severity, a ...

HMPV is an old virus, cases of which have been increasing in the past few months. China saw a significant rise in cases of ...